Clinical trial
Rabeprazole Protection of Aspirin Induced Gastric Damage.
NCT00220857 · Temple University, Other · Completed
Key facts
| NCT number | NCT00220857 |
|---|---|
| Title | Rabeprazole Protection of Aspirin Induced Gastric Damage. |
| Official title | Rapid Protection of the Gastroduodenal Mucosa Against Aspirin-Induced Damage by Rabeprazole |
| Lead sponsor | Temple University, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Normal Subjects |
| Intervention type | Drug |
| Interventions | Rabeprazole |
| Enrollment | 30 |
| Start date | Sep 1, 2005 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Jan 11, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: